Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
21 |
Material Type: Article
|
INHBA is a prognostic predictor for patients with colon adenocarcinomaBMC cancer, 2020-04, Vol.20 (1), p.305-305, Article 305 [Peer Reviewed Journal]COPYRIGHT 2020 BioMed Central Ltd. ;COPYRIGHT 2020 BioMed Central Ltd. ;2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-020-06743-2 ;PMID: 32293338Full text available |
|
22 |
Material Type: Article
|
Advances in personalized radiotherapyBMC cancer, 2024-05, Vol.24 (1), p.556-556 [Peer Reviewed Journal]2024. The Author(s). ;COPYRIGHT 2024 BioMed Central Ltd. ;2024. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-024-12317-3 ;PMID: 38702617Full text available |
|
23 |
Material Type: Article
|
A gene expression-based study on immune cell subtypes and glioma prognosisBMC cancer, 2019-11, Vol.19 (1), p.1116-1116, Article 1116 [Peer Reviewed Journal]COPYRIGHT 2019 BioMed Central Ltd. ;COPYRIGHT 2019 BioMed Central Ltd. ;The Author(s). 2019 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-019-6324-7 ;PMID: 31729963Full text available |
|
24 |
Material Type: Article
|
Exosome-transmitted circ_002136 promotes hepatocellular carcinoma progression by miR-19a-3p/RAB1A pathwayBMC cancer, 2022-12, Vol.22 (1), p.1284-1284 [Peer Reviewed Journal]2022. The Author(s). ;COPYRIGHT 2022 BioMed Central Ltd. ;2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2022 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-022-10367-z ;PMID: 36476239Full text available |
|
25 |
Material Type: Article
|
Identification of a pyroptosis-related prognostic signature in breast cancerBMC cancer, 2022-04, Vol.22 (1), p.429-429, Article 429 [Peer Reviewed Journal]2022. The Author(s). ;COPYRIGHT 2022 BioMed Central Ltd. ;2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2022 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-022-09526-z ;PMID: 35443644Full text available |
|
26 |
Material Type: Article
|
Therapeutic implications of PD-L1 expression in bladder cancer with squamous differentiationBMC cancer, 2020-03, Vol.20 (1), p.230-230, Article 230 [Peer Reviewed Journal]COPYRIGHT 2020 BioMed Central Ltd. ;COPYRIGHT 2020 BioMed Central Ltd. ;2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-020-06727-2 ;PMID: 32188412Full text available |
|
27 |
Material Type: Article
|
Tracking tumor alteration in glioma through serum fibroblast activation protein combined with imageBMC cancer, 2023-10, Vol.23 (1), p.1-1012, Article 1012 [Peer Reviewed Journal]COPYRIGHT 2023 BioMed Central Ltd. ;2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;BioMed Central Ltd., part of Springer Nature 2023 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-023-11544-4 ;PMID: 37864148Full text available |
|
28 |
Material Type: Article
|
Overall survival following stereotactic radiosurgery for ten or more brain metastases: a systematic review and meta-analysisBMC cancer, 2023-10, Vol.23 (1), p.1-1004, Article 1004 [Peer Reviewed Journal]COPYRIGHT 2023 BioMed Central Ltd. ;2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;BioMed Central Ltd., part of Springer Nature 2023 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-023-11452-7Full text available |
|
29 |
Material Type: Article
|
Improved clinical outcomes in advanced hepatocellular carcinoma treated with transarterial chemoembolization plus atezolizumab and bevacizumab: a bicentric retrospective studyBMC cancer, 2023-09, Vol.23 (1), p.1-873, Article 873 [Peer Reviewed Journal]COPYRIGHT 2023 BioMed Central Ltd. ;2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;BioMed Central Ltd., part of Springer Nature 2023 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-023-11389-x ;PMID: 37718456Full text available |
|
30 |
Material Type: Article
|
Prognostic potential of preoperative circulating tumor cells to predict the early progression recurrence in hepatocellular carcinoma patients after hepatectomyBMC cancer, 2023-11, Vol.23 (1), p.1-1150, Article 1150 [Peer Reviewed Journal]COPYRIGHT 2023 BioMed Central Ltd. ;2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-023-11629-0Full text available |
|
31 |
Material Type: Article
|
Identification of prognostic immune-related gene signature associated with tumor microenvironment of colorectal cancerBMC cancer, 2021-08, Vol.21 (1), p.1-905, Article 905 [Peer Reviewed Journal]COPYRIGHT 2021 BioMed Central Ltd. ;2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-021-08629-3 ;PMID: 34364366Full text available |
|
32 |
Material Type: Article
|
Incidence and risk factors of acute kidney injury in patients with malignant tumors: a systematic review and meta-analysisBMC cancer, 2023-11, Vol.23 (1), p.1-1123, Article 1123 [Peer Reviewed Journal]COPYRIGHT 2023 BioMed Central Ltd. ;2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-023-11561-3Full text available |
|
33 |
Material Type: Article
|
Prediction of lymphovascular space invasion using a combination of tenascin-C, cox-2, and PET/CT radiomics in patients with early-stage cervical squamous cell carcinomaBMC cancer, 2021-07, Vol.21 (1), p.1-866, Article 866 [Peer Reviewed Journal]COPYRIGHT 2021 BioMed Central Ltd. ;2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-021-08596-9 ;PMID: 34320931Full text available |
|
34 |
Material Type: Article
|
Clinical retrospective analysis with a predictive model for diffused-tenosynovial giant cell tumors of the temporomandibular jointBMC cancer, 2023-11, Vol.23 (1), p.1-1062, Article 1062 [Peer Reviewed Journal]COPYRIGHT 2023 BioMed Central Ltd. ;2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2023 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-023-11587-7Full text available |
|
35 |
Material Type: Article
|
Prognostic significance of HLA-G in patients with colorectal cancer: a meta-analysis and bioinformatics analysisBMC cancer, 2023-10, Vol.23 (1), p.1-1024, Article 1024 [Peer Reviewed Journal]COPYRIGHT 2023 BioMed Central Ltd. ;2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;BioMed Central Ltd., part of Springer Nature 2023 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-023-11522-wFull text available |
|
36 |
Material Type: Article
|
Overall survival of patients with hepatocellular carcinoma treated with sintilimab and disease outcome after treatment discontinuationBMC cancer, 2023-10, Vol.23 (1), p.1-1017, Article 1017 [Peer Reviewed Journal]COPYRIGHT 2023 BioMed Central Ltd. ;2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;BioMed Central Ltd., part of Springer Nature 2023 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-023-11485-y ;PMID: 37867191Full text available |
|
37 |
Material Type: Article
|
The optimal intravesical maintenance chemotherapy scheme for the intermediate-risk group non-muscle-invasive bladder cancerBMC cancer, 2023-10, Vol.23 (1), p.1-1018, Article 1018 [Peer Reviewed Journal]COPYRIGHT 2023 BioMed Central Ltd. ;2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;BioMed Central Ltd., part of Springer Nature 2023 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-023-11523-9Full text available |
|
38 |
Material Type: Article
|
Analysis of neoadjuvant chemotherapy for breast cancer: a 20-year retrospective analysis of patients of a single institutionBMC cancer, 2023-10, Vol.23 (1), p.1-984, Article 984 [Peer Reviewed Journal]COPYRIGHT 2023 BioMed Central Ltd. ;2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;BioMed Central Ltd., part of Springer Nature 2023 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-023-11505-xFull text available |
|
39 |
Material Type: Article
|
Serum long non-coding RNA SCARNA10 serves as a potential diagnostic biomarker for hepatocellular carcinomaBMC cancer, 2022-04, Vol.22 (1), p.431-431, Article 431 [Peer Reviewed Journal]2022. The Author(s). ;COPYRIGHT 2022 BioMed Central Ltd. ;2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2022 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-022-09530-3 ;PMID: 35443674Full text available |
|
40 |
Material Type: Article
|
MEX3C as a potential target for hepatocellular carcinoma drug and immunity: combined therapy with LenvatinibBMC cancer, 2023-10, Vol.23 (1), p.1-967, Article 967 [Peer Reviewed Journal]COPYRIGHT 2023 BioMed Central Ltd. ;2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;BioMed Central Ltd., part of Springer Nature 2023 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-023-11320-4Full text available |